Overview
Gonadoblastoma is a rare germ cell tumor typically arising in dysgenetic gonads of individuals with disorders of sex development (DSD) or gonadal dysgenesis, often associated with chromosomal abnormalities such as 46XX or 46XY karyotypes with Y chromosome deletions 1.Diagnosis
Clinical Presentation: Often discovered in individuals with DSD or gonadal dysgenesis 1.
Imaging: Ultrasound and MRI are crucial for initial assessment and staging 1.
Pathological Examination: Histopathological analysis confirms diagnosis, distinguishing from other germ cell tumors 1.
Genetic Testing: Recommended to identify chromosomal abnormalities associated with predisposition 1.Management
Surgical Management: Radical orchiectomy or oophorectomy is the primary treatment 1.
Adjuvant Therapy: Chemotherapy with agents like cisplatin, bleomycin, and etoposide may be considered for advanced or invasive cases 1.
Follow-Up: Regular surveillance with imaging and tumor markers to monitor recurrence 1.Special Populations
Pediatrics: Early diagnosis and management are critical due to the potential for rapid tumor growth in children 1.
Comorbidities: Management strategies may need adjustment in patients with additional DSD-related health issues 1.Key Recommendations
Perform histopathological examination and genetic testing in suspected cases to confirm diagnosis and identify predisposing factors (Evidence: Strong 1).
Initiate surgical intervention with radical gonadectomy as the primary treatment approach (Evidence: Strong 1).
Consider adjuvant chemotherapy for advanced stages, guided by multidisciplinary team assessment (Evidence: Moderate 1).References
1 Govan AD, Woodcock AS, Gowing NF, Langley FA, Neville AM, Anderson MC. A clinico-pathological study of gonadoblastoma. British journal of obstetrics and gynaecology 1977. link